MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonus: Etiology and Pathogenesis"

  • 2019 International Congress

    Adult-Onset Parainfectious Opsoclonus-Myoclonus: Report of Two Cases

    MI. Gaston, I. Rubio, J. Muruzabal, R. Larumbe, M. Martin, L. Martinez (Pamplona, Spain)

    Objective: Present two cases of Adult-Onset parainfectious Opsoclonus-Myoclonus Syndrome with fast and good recovery Background: Adult-Onset Opsoclonus-Myoclonus  (AOMS) is a rare disorder. Two main causes…
  • 2019 International Congress

    Steroid-responsive myoclonus in the context of pembrolizumab treatment: a novel neurological phenotype.

    M. Murphy, S. O'Dowd, M. Alexander (Dublin, Ireland)

    Objective: To outline a novel immunologically-mediated neurological adverse event associated with the use of a medication class which has an expanding range of applications [1].…
  • 2019 International Congress

    High dose amantadine therapy may cause increased falling in Parkinson’s patients

    L. Verhagen Metman (Chicago, IL, USA)

    Objective: To report a possible association between high dose amantadine and increased falling in patients with Parkinson’s disease (PD). Background: Amantadine is used in PD…
  • 2018 International Congress

    Tardive Myoclonus: A Case Report

    S. Gazioglu, F. Civil Arslan, V. Altunayoglu Cakmak, M. Korucuk, M. Ozmenoglu (Trabzon, Turkey)

    Objective: To report a patient with late-onset myoclonus after treatment with antipsychotic drugs which is a rare variant of tardive movement disorders. Background: The use…
  • 2018 International Congress

    Myoclonus in the pediatric age group: A retrospective analysis of clinical and electrophysiological characteristics of patients referred to an electrophysiology laboratory

    A. Gunduz, H. Yılmaz, V. Demirbilek, C. Yalçınkaya, N. Yeni, S. Saltık, M. E. Kızıltan (Istanbul, Turkey)

    Objective: We aimed to investigate clinical and electrophysiological features myoclonus in the pediatric age group. Background: Myoclonus is a movement disorder characterized by sudden, brief…
  • 2018 International Congress

    Movement Disorders Phenomenology in Focal Motor Seizures

    A. Fasano, C. Di Bonaventura, F. Bove, A. Espay, F. Morgante, G. Fabbrini, R. Munhoz, D. Andrade, F. Borlot, F. Bui, G. Di Gennaro, R. Iorio, H. Katzberg, M. Luigetti, P. Striano, G. Defazio, A. Berardelli (Toronto, ON, Canada)

    Objective: To examine the extent to which focal motor seizures can present with a phenomenology fulfilling diagnostic criteria for one or more movement disorder. Background:…
  • 2017 International Congress

    Orthostatic myoclonus after brain tumor surgery and radiation

    J. Cutsforth-Gregory, J. Hammack, J. Matsumoto (Rochester, MN, USA)

    Objective: To review the clinical and electrophysiological characteristics of orthostatic myoclonus (OM) in the setting of brain tumor treatment, a novel association. Background: OM is…
  • 2017 International Congress

    Reappraisal of Progressive Myoclonus Ataxia

    S. vd Veen, R. Zutt, T. De Koning, M. Tijssen (Groningen, Netherlands)

    Objective: To define the clinical, electrophysiological and etiological features of progressive myoclonus ataxia (PMA). Background: PMA, formerly known as the Ramsay Hunt syndrome, is a…
  • 2017 International Congress

    Myoclonus in the Elderly: Retrospective Analysis of Clinical and Electrophysiological characteristics of patients referred to an electrophysiology laboratory

    M. Kiziltan, A. Gunduz, M. Tutuncu, U. Uygunoglu, A. Sifoglu, S. Ertan, H. Apaydin, M. Bozluolcay, S. Saip, G. Kiziltan (Istanbul, Turkey)

    Objective: In this report, we aimed to investigate clinical and electrophysiological features of patients with late-onset myoclonus. Background: Myoclonus is characterized by sudden, brief and…
  • 2017 International Congress

    Cefepime-induced encephalopathy and myoclonus

    T. Rasameesoraj, X.x. Yu, A. Ahmed, H. Fernandez (Cleveland, OH, USA)

    Objective: To raise awareness of cephalosporin-induced encephalopathy and myoclonus. Background: Myoclonus occurs in 15% of antibiotic-associated encephalopathy, especially with penicillins and cephalosporins. Cefepime and ceftazidime…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley